10 Must-Read Articles For #ECTRIMS2015


Here is what you need to read before #ECTRIMS2015

1.       Could Genentech’s Ocrelizumab Become the First Effective Primary Progressive MS Therapy?


2.      Ocrelizumab: a Promising New Treatment for Multiple Sclerosis with Minimal Side Effects


3.      Roche’s Ocrelizumab Found to be Superior to Standard Interferon Therapy in Relapsing Multiple Sclerosis Patients


4.      Biogen to Present New Data at Upcoming ECTRIMS 2015 Congress on MS Therapies, Including TECFIDERA


5.      EMD Serono To Present New Data on Rebif, a Therapy for RRMS, at Upcoming ECTRIMS Congress


6.      Receptos Launches SUNBEAM Phase 3 Trial for Relapsing Multiple Sclerosis Therapy


7.      Gut Bacteria: Key to MS?


8.      Most MS Survey Respondents Favor Legal Marijuana Access For Medical Use


9.      Stem Cells Used to Treat Secondary Progressive Patients in Clinical Trial


10.    Study Supports High Intensity Exercise to Improve Muscle Condition in MS Patients


Updates on #ECTRIMS2015

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *